IMAB Chart
See on advanced chart >
About
I-Mab was incorporated in the Cayman Islands on June 30, 2016. The company is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with...
Read More
- HighlightA Chinese biotech company that develops innovative therapies for cancer and autoimmune diseases
- ExchangeNASDAQ
- Listing Date01/17/2020
- Established Date06/30/2016
- Full-time Employees220
- Address2440 Research Boulevard Suite 400 Rockville MD 20850 United States
- Tel1-240-7456330
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Biotechnology